Ana L. Ortega
Jaen, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Characteristics and clinical outcomes of a nationwide cohort of patients with small cell lung cancer following first-line treatment: Real-world evidence.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 17, 2026
Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).
Journal: Archivos de bronconeumologia
Published: January 13, 2026
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.
Journal: Nature communications
Published: May 23, 2025
Biomarker landscape in advanced NSCLC: insights from a national prospective registry.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 23, 2025
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain.
Journal: The Lancet regional health. Europe
Published: April 10, 2025
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.
Journal: Cancer treatment and research communications
Published: November 03, 2024
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.
Journal: Journal of medical economics
Published: October 10, 2024
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry.
Journal: Archivos de bronconeumologia
Published: May 28, 2024
Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 06, 2024
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 08, 2023
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Journal: Archivos de bronconeumologia
Published: November 06, 2023
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
Journal: JCO clinical cancer informatics
Published: July 10, 2023
Last Updated: 09/26/2026